$0.45
+0.03(6.21%)
Mkt Cap $10M
$0.39
$7.78
52-Week Range
At a Glance
AI-generatedMedicus Pharma Ltd.
8-K
Medicus Pharma Ltd. completed sales of 4,471,038 common shares to Yorkville under the Standby Equity Purchase Agreement dated February 10, 2025, for aggregate consideration of approximately $3,846,910. Part of the net proceeds were used to prepay a portion of an outstanding debenture with Yorkville, with shares issued under Section 4(a)(2) exemption.$10M
Market Cap
—
Revenue
-$39M
Net Income
Employees12
Fundamentals
How The Business Makes Money
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.
Industry Biotechnology
Activity
Company Profile
CIK0001997296
ISINCA58471K2020
Address300 Conshohocken State Rd. Suite 200, W. Conshohocken, 19428, CA
SEC EDGAR